HCP Content Marketing for Biotech, Medtech & Pharma

Most HCP content fails one of two tests. It clears MLR review but never earns the clinician’s attention, or it would earn attention but cannot be referenced, so it never clears review.

We build content that passes both. Every message traces to an approved claim, the PI, or cited evidence, and every asset is written with the clinical fluency HCPs expect.

Life-science commercial
teams that run  their HCP
pipeline 
with HCP Compass

24 biotech, medtech, and pharma teams have started an engagement with us.
Senior operators run every account end-to-end

Johnson & Johnson
Amgen
Netherlands Cancer Institute
Boehringer Ingelheim
Merck
AstraZeneca
Omron
Novartis
mindray
Gilead
Pfizer
Novo Nordisk

Why most HCP content
fail in review or in practice

You have probably hired one already. Three reasons the model breaks.

Six standards every piece
of HCP content needs.

Skip any one and the asset stalls in review or fails with its audience. Every piece we produce meets all six.

Every message traces to an approved claim, the PI, or cited clinical evidence. Nothing gets drafted that cannot be referenced.

Assets arrive with references annotated and files structured for Veeva PromoMats. Review starts from a complete submission, not a reconstruction.

A Doximity placement, a LinkedIn ad, and an HCP email have different reading contexts and different compliance surfaces. Each asset is built for its own.

Channel variants are planned from the same approved claims structure before production starts, so one review can cover the asset family.

Written by teams that work from the study design, the endpoints, and the limits of what the data supports. HCPs recognise the difference immediately.

Built to meet FDA OPDP expectations in the US and EMA guidance with EFPIA and national codes in Europe, so the same campaign can run in both markets without a rebuild.

Create is stage two of a four-stages system.

Content at HCP Compass executes the strategy defined in Stage 01. The pain points of your audience, the clinical and commercial understanding of your product, and its value proposition all carry into creation. Every asset is built toward the outcome the strategy defined, not produced in isolation.

Stage 02 - HCP Compass
HCP Content deliverables

How HCP content gets built.

Brief, claims mapping, production, submission. Four phases from input to approved asset.

Content creation process

Brief intake

We work from the strategy defined in Stage 01, aligned with where you, your competitors, and your product positioning stand. Audience, channels, and KPIs are agreed before anything gets written.

Claims mapping

Concepts are developed against your approved claims library and PI. What cannot be referenced does not get drafted.

Production

Copy and creative built per channel, with variants planned from the shared claims structure. Medical accuracy is checked before delivery.

Submission and handoff

Assets are delivered annotated and structured per channel, with a complete overview of how each piece fits within the campaign. We work reviewer feedback through to approval.

HCP content
Frequently Asked Questions

Arjun Shailly - HCP Compass

The HCP marketing field guide

Four deeper guides across HCP demand generation, compliance, and measurement. Practitioner-direct, for the people who own the budget.